Search Results - "SIEGALL, C"
-
1
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Published in Nature biotechnology (01-07-2003)“…We describe the in vitro and in vivo properties of monoclonal antibody (mAb)-drug conjugates consisting of the potent synthetic dolastatin 10 analogs…”
Get full text
Journal Article -
2
Agonistic properties and in vivo antitumor activity of the anti-CD40 antibody SGN-14
Published in Cancer research (Chicago, Ill.) (15-06-2000)“…Ligation of CD40 is essential for primary B-cell activation and expansion and yet has suppressive or apoptotic effects on some CD40-expressing neoplasia…”
Get full text
Journal Article -
3
Characterization of vascular leak syndrome induced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with nonsteroidal anti-inflammatory drugs
Published in Clinical cancer research (01-03-1997)“…Clinical trials of immunotoxins in cancer patients have been limited in many cases by vascular leak syndrome (VLS). Recently, rats were identified as a model…”
Get full text
Journal Article -
4
Targeted toxins as anticancer agents
Published in Cancer (01-08-1994)“…Transformed cells, such as those found in breast cancer, often overexpress a variety of cell surface receptors and antigens. Antibodies or growth factors that…”
Get more information
Journal Article -
5
Characterization of an Interleukin-6-Mediated Autocrine Growth Loop in the Human Multiple Myeloma Cell Line, U266
Published in Blood (01-02-1991)“…It has been reported recently that freshly isolated human myeloma cell cultures proliferate in response to added interleukin-6 (IL-6). Endogenous levels of…”
Get full text
Journal Article -
6
Functional Analysis of Domains II, Ib, and III of Pseudomonas exotoxin
Published in The Journal of biological chemistry (25-08-1989)“…Pseudomonas exotoxin is composed of three structural domains that are responsible for cell recognition, membrane translocation, and ADP-ribosylation. The…”
Get full text
Journal Article -
7
Advances in immunotoxin biology and therapy: a summary of the Fourth International Symposium on Immunotoxins
Published in Cancer research (Chicago, Ill.) (15-02-1996)Get full text
Journal Article -
8
Prevention of Immunotoxin-Mediated Vascular Leak Syndrome in Rats with Retention of Antitumor Activity
Published in Proceedings of the National Academy of Sciences - PNAS (27-09-1994)“…Immunotoxins are hybrid molecules composed of a cell-surface binding domain and a protein toxin moiety that together target specific cell populations for…”
Get full text
Journal Article -
9
BR96 sFv-PE40 Immunotoxin: Nonclinical Safety Assessment
Published in Toxicologic pathology (01-01-1999)“…BR96 sFv-PE40, a recombinant DNA-derived fusion protein composed of the heavy- and light-chain variable region domains of the monoclonal antibody BR96 and the…”
Get full text
Journal Article Conference Proceeding -
10
In vitro and in vivo characterization of BR96 sFv-PE40. A single-chain immunotoxin fusion protein that cures human breast carcinoma xenografts in athymic mice and rats
Published in The Journal of immunology (1950) (01-03-1994)“…BR96 sFv-PE40 is a single-chain immunotoxin fusion protein targeted to the Ley Ag, which is expressed in many different human carcinomas as well as in normal…”
Get full text
Journal Article -
11
Antitumor activity of the single-chain immunotoxin BR96 sFv-PE40 against established breast and lung tumor xenografts
Published in The Journal of immunology (1950) (01-04-1993)“…We have constructed a single-chain immunotoxin consisting of the variable H and L chains of the carcinoma-reactive mAb BR96, fused to the binding defective…”
Get full text
Journal Article -
12
Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen
Published in Cancer research (Chicago, Ill.) (15-07-1995)“…We have constructed anti-CD40 immunotoxins consisting of the single chain Fv (sFv) region of the anti-human CD40 mAb G28-5 fused to a truncated form of…”
Get full text
Journal Article -
13
In Vivo Efficacy and Toxicity of a Single-Chain Immunotoxin Targeted to CD40
Published in Blood (15-06-1997)“…G28-5 sFv-PE40 is a single-chain immunotoxin targeted to CD40, which is highly expressed on human hematologic malignancies, including non-Hodgkin's lymphoma,…”
Get full text
Journal Article -
14
Cytotoxic activities of a fusion protein comprised of TGF alpha and Pseudomonas exotoxin
Published in The FASEB journal (01-12-1989)“…A cDNA encoding transforming growth factor type alpha (TGF alpha) was fused to the 5' end of a gene encoding a modified form of Pseudomonas exotoxin A (PE),…”
Get more information
Journal Article -
15
Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells
Published in Circulation (New York, N.Y.) (01-08-1991)“…Restenosis after percutaneous transluminal coronary angioplasty is associated with activation of medial smooth muscle cells (SMCs); they proliferate, migrate…”
Get full text
Journal Article -
16
Selective tumor sensitization to taxanes with the mAb‐drug conjugate cBR96‐doxorubicin
Published in International journal of cancer (15-08-2001)“…The chimeric monoclonal antibody cBR96 conjugated to doxorubicin (cBR96‐Dox) is selectively internalized by a wide variety of human carcinomas expressing an…”
Get full text
Journal Article -
17
-
18
Cytotoxic Activity of an Interleukin 6--Pseudomonas Exotoxin Fusion Protein on Human Myeloma Cells
Published in Proceedings of the National Academy of Sciences - PNAS (01-12-1988)“…A chimeric toxin composed of human interleukin 6 (IL-6) attached to a portion of Pseudomonas exotoxin (PE) devoid of its own cell recognition domain has been…”
Get full text
Journal Article -
19
BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells
Published in Cancer research (Chicago, Ill.) (15-01-1993)“…We have constructed a single-chain immunotoxin composed of the carcinoma-reactive antibody BR96 and a truncated form of Pseudomonas exotoxin. The chimeric…”
Get full text
Journal Article -
20
Betacellulin-Pseudomonas toxin fusion proteins bind but are not cytotoxic to cells expressing HER4; correlation of EGFR for cytotoxic activity
Published in Oncogene (05-03-1998)“…Betacellulin (BTC) is a member of the EGF ligand family that directly binds to both EGFR and HER4 and induces the growth of certain epithelial cell types…”
Get full text
Journal Article